These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7907104)

  • 1. T cell receptor recognition of MHC class II alloantigens is highly cell type dependent.
    Katz JF; Sant AJ
    J Immunol; 1994 Feb; 152(4):1629-40. PubMed ID: 7907104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
    St Pierre Y; Watts TH
    J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants.
    Dang LH; Michalek MT; Takei F; Benaceraff B; Rock KL
    J Immunol; 1990 Jun; 144(11):4082-91. PubMed ID: 1971292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
    Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
    J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
    Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
    Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of non-adhesive T-cell-accessory cell interactions in the induction of T-cell proliferative hyporesponsiveness.
    Ibrahim MA; Chain BM; Katz DR
    Immunology; 1994 Apr; 81(4):521-31. PubMed ID: 7913693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
    Tite JP; Sloan A; Janeway CA
    J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of antibodies to Lyt-2 and L3T4 on cytolysis by cloned, Ia-restricted T cells expressing both proteins.
    Jones B; Khavari PA; Conrad PJ; Janeway CA
    J Immunol; 1987 Jul; 139(2):380-4. PubMed ID: 3110269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Promiscuous T cell hybridoma derived from NOD mouse].
    Katoh M
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):275-88. PubMed ID: 7774880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
    Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
    Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
    Kuijpers KC; Treep-Van Leeuwen P; Miedema F; Lucas CJ
    Eur J Immunol; 1991 Jun; 21(6):1453-60. PubMed ID: 1710566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor.
    Nalefski EA; Rao A
    J Immunol; 1993 May; 150(9):3806-16. PubMed ID: 7682584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.